Table 1 Comparison of clinical characteristics between the two groups
Clinical parameters | DKD Group(n = 25) | NDKD Group(n = 34) | Z/t/x2 | P value |
|---|---|---|---|---|
Male(number, %) | 17(68) | 18(53) | 1.354 | 0.245 |
Age (years,‾x ± s) | 48.36 ± 12.26 | 53.12 ± 10.90 | -1.571 | 0.122 |
Hypertension(number, %) | 19(76) | 20(59) | 1.897 | 0.168 |
Tobacco smoking(number, %) | 8(32) | 4(12) | 3.641 | 0.056 |
Alcohol drinking(number, %) | 2(8) | 5(15) | 0.620 | 0.431 |
DR(number, %) | 14(56) | 4(12) | 13.297 |  < 0.001 |
BMI [kg/m2, M (Q1, Q3)] | 24.97(22.54,26.26) | 22.86(21.48,27.68) | -0.784 | 0.433 |
SBP(mmHg, ‾x ± s) | 154.48 ± 22.95 | 138.56 ± 17.04 | 3.060 | 0.003 |
DBP [mmHg, M(Q1,Q3)] | 87(80,100) | 80(73,94) | -1.169 | 0.242 |
Diabetes duration [month, M (Q1, Q3)] | 60(24,132) | 12(6,72) | -2.418 | 0.016 |
HbA1C [%, M (Q1, Q3)] | 7.00(5.75,9.37) | 7.10(6.70,7.90) | -0.133 | 0.894 |
Hb (g/L, ‾x ± s) | 113.40 ± 21.32 | 135.15 ± 20.34 | -3.977 |  < 0.001 |
FPG (mmol/L, ‾x ± s) | 8.12 ± 3.43 | 6.80 ± 2.08 | 1.716 | 0.095 |
ALB(g/L,‾x ± s) | 34.09 ± 7.63 | 30.94 ± 9.39 | 1.379 | 0.173 |
TC (mmol/L,‾x ± s) | 6.08 ± 1.94 | 8.00 ± 2.96 | -3.020 | 0.004 |
TG [mmol/L, M (Q1, Q3)] | 1.57(1.22,1.98) | 2.95(1.62,4.24) | -2.715 | 0.007 |
HDL-C (mmol/L,‾x ± s) | 1.34 ± 0.38 | 1.47 ± 0.46 | -1.140 | 0.259 |
LDL-C [mmol/L, M (Q1, Q3)] | 2.97(2.42,4.40) | 3.90(3.04,6.35) | -1.902 | 0.057 |
Cys-C [mg/L, M(Q1,Q3)] | 1.11(0.89,1.74) | 0.83(0.69,0.92) | -3.944 |  < 0.001 |
TG/Cys-C ratio [M(Q1,Q3)] | 1.24(0.75,1.91) | 2.78(1.82,5.01) | -4.126 |  < 0.001 |
Scr [umol/L, M(Q1,Q3)] | 118.00(73.75,145.50) | 64.00(47.00,82.00) | -3.399 | 0.001 |
UA (umol/L, ‾x ± s) | 319.57 ± 75.78 | 346.39 ± 84.90 | -1.254 | 0.215 |
eGFR(ml/min /1.73m2, x ± s) | 72.30 ± 36.59 | 104.20 ± 40.54 | -3.110 | 0.003 |
UPE, [g/24Â h, M(Q1,Q3)] | 5.04(3.89,8.00) | 3.83(2.14,7.47) | -0.895 | 0.371 |
Hematuria(number, %) | 16(64) | 19(56) | 0.600 | 0.438 |
FIB (g/L,‾x ± s) | 4.34 ± 1.52 | 4.27 ± 1.13 | 0.199 | 0.843 |